of investments in associates (1.44) (2.62) (1.19) 82.53% (1.61) (7.65) (6.04) 374.61% Finance costs (0.07) (0.12) (0.04) 55.07% (0.14) (0.22) (0.08) 60.46% Profit before income tax expense (0.30) 8.88
expense approximately by Baht 510 - 940 Million through the concession agreement period. 2. On June 28, 2018, the Company sold all 7.5 percent of investment in Xayaburi Power Company Limited (XPCL) to CK
expenses, and other selling expenses such as marketing and promotional expenses, and depreciation of asset in each branch. In Quarter 1/ 2019 and Quarter 1/2018, the Company incurred selling expense totaling
. Administrative and Selling Expenses Selling, general, and administrative expense as a percent of sales increased slightly to 13.2% in 2Q17 compared to 12.5% in the previous quarter. Selling expense increased in
helped lessen the effect of the above on profit margin. Administrative and Selling Expenses Selling, general, and administrative expense as a percent of sales increased slightly to 13.5% in 3Q17 compared
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
Administrative Expenses (69.3) (152.9) (83.6) 120.6 Finance Costs (404.0) (459.9) (55.9) 13.8 Share of Profit from Investments in Associates and Joint Ventures 962.5 1,936.1 973.7 101.2 Income Tax (Expense) Income
last year, resulted from profit and loss from exchange rate and profit from selling unused assets. 3. Adminstrative expenses On 1st Quarter, 2019, the Group’s administrative expense total amount of 21.86